-
Central Venous Pressure Revisited: Physiology, Pitfalls, Misconceptions, and Modern Clinical Interpretation in Critical Care -
Current Trends and Future Challenges in Transcatheter Aortic Valve Implantation (TAVI): A Narrative Review -
Novel Combination Scalp Therapy for Androgenetic Alopecia: A Preliminary Retrospective Case Series with an Illustrative Four-Year Case -
A Sensorimotor Framework for the Neurorehabilitation of Oculomotor Dysfunction in Parkinson’s Disease -
The History of the Precordial Early Repolarization and Sudden Death Syndrome, Lately Named Brugada Syndrome
Journal Description
Journal of Clinical Medicine
Journal of Clinical Medicine
is an international, peer-reviewed, open access journal of clinical medicine, published semimonthly online by MDPI. The International Bone Research Association (IBRA), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
- Journal Rank: JCR - Q1 (Medicine, General and Internal) / CiteScore - Q1 (General Medicine)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 16.6 days after submission; acceptance to publication is undertaken in 2.8 days (median values for papers published in this journal in the first half of 2026).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Companion journals for JCM include: Epidemiologia, Transplantology, Uro, Sinusitis, Rheumato, Journal of Clinical & Translational Ophthalmology, Journal of Vascular Diseases, Osteology, Complications, Therapeutics, Sclerosis, Pharmacoepidemiology, Journal of CardioRenal Medicine, Rare Diseases and Therapeutics and Journal of Respiration.
- Journal Clusters of Hematology: Hemato, Hematology Reports, Thalassemia Reports and Journal of Clinical Medicine.
Impact Factor:
3.3 (2025);
5-Year Impact Factor:
3.5 (2025)
Latest Articles
Beyond Maximum Haemorrhage Grade: Serial Cranial Ultrasound Phenotyping Refines Developmental Risk Stratification After Intraventricular Haemorrhage in Very Preterm Infants
J. Clin. Med. 2026, 15(16), 6310; https://doi.org/10.3390/jcm15166310 - 14 Aug 2026
Abstract
Background/Objectives: In neonatal intensive care, intraventricular haemorrhage (IVH) is one of the most frequent brain morbidities in very preterm infants, but maximum IVH grade may not fully capture developmental risk. We assessed whether a serial cranial ultrasound (CUS) phenotype integrating IVH grade,
[...] Read more.
Background/Objectives: In neonatal intensive care, intraventricular haemorrhage (IVH) is one of the most frequent brain morbidities in very preterm infants, but maximum IVH grade may not fully capture developmental risk. We assessed whether a serial cranial ultrasound (CUS) phenotype integrating IVH grade, associated parenchymal lesion visible on serial CUS (visible APL) and ventricular morbidity refined developmental risk stratification. Methods: We studied 2756 very preterm infants from a single-centre cohort of 3081 who had at least two protocolised CUS examinations. IVH was classified by maximum serial CUS grade. Visible APL, severe ventriculomegaly (VM), post-haemorrhagic hydrocephalus (PHH), cerebral palsy (CP), clinically classified school-age cognitive sequelae and sustained developmental/educational support were analysed. Results: Visible APL and ventricular morbidity increased with maximum IVH grade. Among infants with grade 3 IVH (IVH3), visible APL was present in 60.5%, severe VM in 40.8% and PHH in 21.7%. In the isolated-IVH analysis, CP occurred in 1.4% of the reference group (no IVH/no visible APL), 2.9% with isolated grade 1 IVH, 2.8% with isolated grade 2 IVH and 27.5% with IVH3. Isolated IVH3 was associated with CP (aOR 28.55, 95% CI 11.31–72.11), school-age cognitive sequelae and sustained support. After adding severe VM, the CP aOR for isolated IVH3 attenuated to 12.94, while severe VM remained associated with CP, cognitive sequelae and support. Conclusions: Our findings support interpreting IVH as a multidimensional serial CUS risk-stratification phenotype beyond maximum grade alone, with the potential to inform bedside counselling and targeted developmental follow-up in neonatal intensive care, pending external validation.
Full article
(This article belongs to the Special Issue Risk Factors in Neonatal Intensive Care)
Open AccessArticle
Diagnostic Delay and Clinical Follow-Up Across Oral Lichen Planus Phenotypes: A Retrospective Cohort Study
by
Keren Martí De Gea, Massimo Petruzzi and Pia López-Jornet
J. Clin. Med. 2026, 15(16), 6309; https://doi.org/10.3390/jcm15166309 - 14 Aug 2026
Abstract
Background: Oral lichen planus is a chronic oral potentially malignant disorder requiring timely diagnosis and long-term follow-up, yet its diagnostic pathway remains poorly characterised. This study assessed diagnostic and follow-up intervals in patients with oral lichen planus and explored associated clinical and healthcare-related
[...] Read more.
Background: Oral lichen planus is a chronic oral potentially malignant disorder requiring timely diagnosis and long-term follow-up, yet its diagnostic pathway remains poorly characterised. This study assessed diagnostic and follow-up intervals in patients with oral lichen planus and explored associated clinical and healthcare-related factors. Methods: This retrospective cohort study included 199 patients with clinically and histopathologically confirmed oral lichen planus managed at the Oral Medicine Unit of the University of Murcia. Diagnostic time points were defined using an adapted Aarhus framework. Patient, primary care, specialist diagnostic and total intervals were analysed using multivariable quasi-Poisson regression. Loss to follow-up was assessed using Cox regression. Results: Older age was associated with longer patient, primary care and total intervals. Women had a shorter patient interval than men (IRR = 0.44; 95% CI: 0.21–0.91; p = 0.03), but a longer primary care interval (IRR = 3.09; 95% CI: 1.12–10.2; p = 0.04). Compared with erosive oral lichen planus, mixed and reticular forms showed shorter primary care intervals and shorter specialist diagnostic intervals, with IRRs ranging from 0.21 to 0.36 (all p < 0.01). Daily alcohol consumption was associated with the longest total interval. Older age was associated with a higher risk of loss to follow-up (HR = 1.02; 95% CI: 1.00–1.04; p = 0.01), whereas non-pharmacological treatment was associated with a lower hazard of loss to follow-up (HR = 0.31; 95% CI: 0.16–0.60; p < 0.001). Conclusions: Diagnostic delay in oral lichen planus is multifactorial and appears to depend on patient characteristics, clinical presentation and healthcare pathway factors. Improved recognition of erosive disease, clearer referral criteria and structured follow-up strategies may enhance care continuity.
Full article
(This article belongs to the Special Issue Paradigms, Advances and Future Directions in Oral Medicine)
►▼
Show Figures

Figure 1
Open AccessArticle
Comparison of Different Upfront Two-Stent Strategies for True Coronary Bifurcation Lesions: In-Hospital and 6-Month MACE Results
by
Kerim Esenboga, Alparslan Kurtul, Emre Ozerdem, Yakup Yunus Yamanturk, Halil Gulyigit, Muge Akbulut and Eralp Tutar
J. Clin. Med. 2026, 15(16), 6308; https://doi.org/10.3390/jcm15166308 - 14 Aug 2026
Abstract
Background: Percutaneous coronary intervention (PCI) remains controversial for coronary bifurcation lesions (CBLs), and over the years, several stent techniques have been developed. Current guidelines on myocardial revascularization recommend an upfront two-stent strategy (U2SS) for complex CBLs. This study was aimed at comparing different
[...] Read more.
Background: Percutaneous coronary intervention (PCI) remains controversial for coronary bifurcation lesions (CBLs), and over the years, several stent techniques have been developed. Current guidelines on myocardial revascularization recommend an upfront two-stent strategy (U2SS) for complex CBLs. This study was aimed at comparing different upfront two-stenting techniques for true complex CBLs. Methods: We retrospectively analyzed 142 consecutive patients with true coronary bifurcation lesions who underwent percutaneous coronary intervention using an upfront two-stent strategy (DK-crush, mini-culotte, or T/TAP) between June 2019 and September 2022. Clinical, angiographic, and procedural characteristics, as well as 6-month clinical outcomes, were compared among the three groups. The primary endpoint was major adverse cardiovascular events (MACE), and independent predictors of MACE were evaluated using a multivariable Firth penalized logistic regression analysis. Results: Major adverse cardiac events (MACE) [a composite of death, stent thrombosis, myocardial infarction, and target vessel revascularization] occurred in 6.3% of the study population at a median follow-up period of 6 months. There were no significant differences in the primary clinical outcomes among the groups. Although the DK-crush group had the lowest observed incidence of MACE, this difference did not reach statistical significance (p = 0.137). A multivariable Firth penalized logistic regression analysis identified previous myocardial infarction as the only independent predictor of MACE (adjusted OR: 4.33; 95% CI: 1.10–23.61; p = 0.035). Conclusions: Within the limitations of this study, all upfront two-stent strategies appeared feasible and were associated with relatively low short-term MACE rates. No significant differences in clinical outcomes were observed among the evaluated techniques. Previous myocardial infarction was identified as an independent predictor of MACE in the multivariable analysis.
Full article
(This article belongs to the Special Issue Interventional Treatment of Coronary Artery Disease: Clinical Insights and Current Practice)
Open AccessArticle
Maternal and Umbilical Cord Blood Levels of Lead and Cadmium in Sudanese Women with Preeclampsia
by
Alaeldin Elhadi, Manal N. Sharif, Hamdan Z. Hamdan, Ishag Adam and Mohamed F. Lutfi
J. Clin. Med. 2026, 15(16), 6307; https://doi.org/10.3390/jcm15166307 - 14 Aug 2026
Abstract
Background/Objectives: Previous studies hypothesized that significant exposure to lead (Pb) and/or cadmium (Cd) induces preeclampsia in pregnant women with subsequent unfavorable obstetric outcomes. This study aimed to compare maternal (Pb and Cd) and umbilical cord (Pb and Cd) levels between patients with preeclampsia
[...] Read more.
Background/Objectives: Previous studies hypothesized that significant exposure to lead (Pb) and/or cadmium (Cd) induces preeclampsia in pregnant women with subsequent unfavorable obstetric outcomes. This study aimed to compare maternal (Pb and Cd) and umbilical cord (Pb and Cd) levels between patients with preeclampsia and healthy control pregnant women and investigate the variables that are associated with preeclampsia. In addition, the possible influences of these heavy metals on birth weight were assessed. Methods: A case–control study involving 60 women in each group was conducted at the Maternity Hospital in Omdurman, Sudan, between January and June 2021, and included pregnant women residing in Omdurman city, Khartoum state, Sudan. A structured questionnaire was used to gather clinical and medical history. Maternal and cord blood concentrations of Pb and Cd were measured using an atomic absorption spectrophotometer. Univariate and multivariate binary logistic regression analyses were conducted to identify variables associated with preeclampsia. Results: The average maternal age in cases was 25.2 (6.1) years, and in the control group, it was 27.7 (7.2) years. All included participants were residing in Omdurman city, Khartoum state. Preeclampsia patients exhibited significantly elevated mean (SD) levels of umbilical cord Pb [14.2 (5.3) vs. 10.2 (4.5) µg/L, p < 0.001], and median (25th–75th quartile) maternal Cd [3.5 (2.0─6.7) vs. 3.0 (2.0─ 4.0) µg/L, p = 0.021] and umbilical cord Cd [5.0 (3.0─8.1) vs. 2.5 (1.0─4.0) µg/L, p < 0.001] compared with healthy controls. Mean (SD) of umbilical cord Pb level was lower than maternal Pb [14.2 (5.3) vs. 15.7 (7.8) µg/L, p = 0.246), but not reached statistical significance, while median (25th–75th quartile) concentration of umbilical cord Cd and maternal Cd remained comparable [5.0 (3.0─8.1) vs. 3.5 (2.0─ 6.7) µg/L, p = 0.093], in patients with preeclampsia. Levels of umbilical cord Cd correlated inversely with birth weight [Sperman's correlation coefficient (rho) = −0.689, p = 0.013]. Umbilical cord Pb [aOR = 1.29; 1.09 to 1.54; p = 0.003], and Cd [aOR = 1.37; 1.08 to 1.73; p = 0.007], in addition to maternal Cd [aOR = 1.35; 1.06 to 1.72; p = 0.012], were among the variables that are significantly associated with preeclampsia in univariate and multivariate analysis. Conclusions: Umbilical cord Pb, maternal Cd, and umbilical cord Cd concentrations were elevated in pre-eclamptic patients compared with healthy parturient controls and associated with preeclampsia. The preferential higher availability of Cd, but not Pb, in fetal compared with maternal blood might explain why umbilical cord Cd, but not umbilical cord Pb, had a significant negative effect on birthweight.
Full article
(This article belongs to the Special Issue Pregnancy Complications and Maternal-Perinatal Outcomes)
Open AccessSystematic Review
The Role of Circulating MicroRNAs as Biomarkers and Therapeutic Targets in Venous Thromboembolism: A Systematic Review
by
Bulent Kantarcioglu, Hande Nur Erölmez, Mira Nigudkar, Martin Lundy, Fakiha Siddiqui, Prakasha Kempaiah, Chongyu Zhang, Grigoris Gerotziafas, Walter Keith Jones and Jawed Fareed
J. Clin. Med. 2026, 15(16), 6306; https://doi.org/10.3390/jcm15166306 - 14 Aug 2026
Abstract
Introduction: Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cardiovascular disorder and a leading cause of vascular mortality. MicroRNAs (miRNAs) are small endogenous noncoding RNAs that regulate gene expression post-transcriptionally by binding to the target messenger
[...] Read more.
Introduction: Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cardiovascular disorder and a leading cause of vascular mortality. MicroRNAs (miRNAs) are small endogenous noncoding RNAs that regulate gene expression post-transcriptionally by binding to the target messenger RNAs (mRNAs), inducing mRNA degradation or translational repression. miRNA dysregulation likely contributes to VTE pathogenesis. This review comprehensively summarizes current evidence on miRNAs in VTE, offering a structured overview of the existing literature. Materials and Methods: Eligibility criteria were defined using the Population, Intervention/Exposure, Comparator, Outcomes, and Study design (PICOS) framework. A comprehensive literature search in PubMed and EMBASE was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Given methodological heterogeneity, a narrative synthesis was undertaken. Results: Among the 156 studies included in this review, 99 investigated miRNAs in DVT, 25 examined the role of miRNAs in PE, and 32 evaluated miRNA involvement in VTE. These miRNAs were categorized as prothrombotic, antithrombotic, or unclassified based on their reported functional roles. Conclusions: This systematic review highlights the impact of miRNAs in the pathophysiology of VTE and provides a resource for future mechanistic and translational research. The findings emphasize the need for standardized, large-scale studies focusing on human-specific models to validate miRNAs as diagnostic, prognostic biomarkers, and as therapeutic targets in VTE.
Full article
(This article belongs to the Section Hematology)
Open AccessArticle
Single-Access Transfemoral TAVI with a Balloon Expandable Valve: Age-Stratified Analysis of Clinical Outcomes
by
Sushant Saluja, Muntaser Omari, Omran Abukhalaf, Debbie Stewart, Sarah Lamb, Timothy Cartlidge, Richard Edwards, Rajiv Das, Azfar Zaman, Mohamed Farag and Mohammad Alkhalil
J. Clin. Med. 2026, 15(16), 6305; https://doi.org/10.3390/jcm15166305 - 14 Aug 2026
Abstract
Background: Single-access transfemoral transcatheter aortic valve implantation (TAVI) reduces the need for multiple vascular access and therefore, the related risk of related complications. However, the impact of patient age on its clinical outcomes remains uncertain. Methods: This is a secondary analysis of
[...] Read more.
Background: Single-access transfemoral transcatheter aortic valve implantation (TAVI) reduces the need for multiple vascular access and therefore, the related risk of related complications. However, the impact of patient age on its clinical outcomes remains uncertain. Methods: This is a secondary analysis of previously reported propensity score matched study comparing clinical outcomes of single- versus dual-access transfemoral TAVI using SAPIEN-3-Ultra. We examined the relation between patient age, access strategy and outcomes—specifically, 30-day safety endpoint according to the Valve Academic Research Consortium 3 (VARC-3) and major adverse cardiovascular events (MACE), defined as death, permanent pacemaker, neurological or vascular complications—using logistic regression interaction analyses, and restricted cubic spline modelling. Results: A total of 204 patients (propensity score-matched cohort) were included in the study. The elderly group were more likely to have hypertension, peripheral vascular disease or stroke. The use of single access was comparable. The elderly cohort demonstrated a tendency toward longer fluoroscopy and procedural times compared with the non-elderly group. This pattern likely reflects the greater technical complexity and heightened procedural caution often associated with older patients, including more challenging vascular anatomy and the need for careful device handling. Although not statistically significant, these findings remain clinically meaningful and are consistent with the notion that procedures in elderly patients frequently require more meticulous planning and execution. There was a significant interaction between access strategy and age in reducing MACE, but not in VARC-3 safety outcomes. Single access was associated with a significant reduction in MACE (5.4% vs. 26.7%, p = 0.015) with comparable technical and safety outcomes when compared with elderly patients who underwent dual-access TAVI. Conclusions: Single-access TAVI was linked to favourable early outcomes, maintained procedural success, and suggested a possible age-dependent pattern in the occurrence of MACE. Our findings support the need for randomised studies to demonstrate superiority of single- versus dual-access TAVI, particularly in the elderly population.
Full article
(This article belongs to the Special Issue Transcatheter Aortic Valve Implantation and Replacement: Prospects and Challenges—2nd Edition)
►▼
Show Figures

Figure 1
Open AccessSystematic Review
Lower-Limb Motor Function, Mobility, Balance, Falls and Intervention Effects in Inclusion Body Myositis: A Systematic Review
by
Dhruv Nandakumar, Manuel Lubinus and Woohyoung Jeon
J. Clin. Med. 2026, 15(16), 6304; https://doi.org/10.3390/jcm15166304 - 14 Aug 2026
Abstract
Background/Objectives: Inclusion body myositis (IBM) causes progressive, quadriceps-predominant weakness that impairs mobility and increases fall risk, yet outcomes most relevant to independence remain unsynthesized for IBM. This review compiles direct IBM evidence across five domains (A1–A5): natural history, motor performance, falls and balance,
[...] Read more.
Background/Objectives: Inclusion body myositis (IBM) causes progressive, quadriceps-predominant weakness that impairs mobility and increases fall risk, yet outcomes most relevant to independence remain unsynthesized for IBM. This review compiles direct IBM evidence across five domains (A1–A5): natural history, motor performance, falls and balance, sensory/peripheral-nerve function, and interventions. Methods: Eight databases and two trial registers were searched without date or language limits. Eligible studies enrolled adults with IBM based on recognized criteria reporting lower-limb strength or function, gait, transitional tasks, balance, falls, or intervention outcomes; mixed-myopathy cohorts required extractable IBM-specific data. Two reviewers independently screened, extracted, and appraised risk of bias, following PRISMA 2020. Results: Sixty-four studies were included; per-domain totals (A1: 16, A2: 9, A3: 6, A4: 2, and A5: 38) exceed 64 because studies may span domains. Quadriceps strength was the most sensitive progression marker, detected earlier by quantitative testing. Falls were near-universal and insufficiently managed. No drug showed convincing functional benefit in controlled trials, whereas exercise and orthotic/robotic assistance appeared to be safe in small studies. Sensory and peripheral-nerve dysfunction were common, but proprioceptive acuity and postural balance were unmeasured. Conclusions: IBM progression is best measured by quantitative quadriceps strength and function. Intervention evidence derives largely from small, uncontrolled and neutral trials. Primary myopathy is likely the principal driver of decline, but its downstream consequences—for balance, proprioception, and falls—remain underexplored and are the priority for future study.
Full article
(This article belongs to the Special Issue Neuromuscular Diseases and Musculoskeletal Disorders)
►▼
Show Figures

Figure 1
Open AccessReview
Management of Syncope in Geriatric Patients: Are 2018 European Society of Cardiology Guidelines Still Relevant?
by
Barbara Antonazzo, Anna Sirignano, Martina Salvini, Francesca Flavia Rossi, Stefano Ronzoni, Agnese Dorizzi, Kenneth Ellenbogen, Giuseppe Biondi-Zoccai and Simone Calcagno
J. Clin. Med. 2026, 15(16), 6303; https://doi.org/10.3390/jcm15166303 - 14 Aug 2026
Abstract
Syncope in older adults is common, heterogeneous, and frequently misclassified as an unexplained fall, leading to injury, fear of recurrence, and costly, low-yield testing and hospitalization. The 2018 European Society of Cardiology (ESC) Guidelines emphasize structured initial evaluation (history with witnesses, orthostatic blood
[...] Read more.
Syncope in older adults is common, heterogeneous, and frequently misclassified as an unexplained fall, leading to injury, fear of recurrence, and costly, low-yield testing and hospitalization. The 2018 European Society of Cardiology (ESC) Guidelines emphasize structured initial evaluation (history with witnesses, orthostatic blood pressure, and 12-lead ECG), risk-feature-guided disposition, and targeted second-line investigations rather than routine neuroimaging or carotid duplex ultrasound. We performed a structured narrative review anchored to the ESC 2018 Guidelines, searching MEDLINE/PubMed up to February 2026 for randomized trials, observational cohorts, and systematic reviews with substantial representation of adults aged ≥65 years and extracting geriatric-relevant outcomes including injury, falls, admission, arrhythmic diagnoses, and short-term serious events. Evidence since 2018 supports the enduring value of the ESC 2018 Guidelines’ framework but highlights the need for geriatric adaptation: repeated orthostatic phenotyping (including post-prandial and delayed hypotension), systematic deprescribing, and explicit integration of frailty, cognition, and trauma risk into disposition decisions. Post-2018 data strengthen mechanism-based strategies, including earlier implantable loop recorders with remote monitoring and selective pacing for tilt-induced asystolic reflex syncope, while cardioneuroablation remains investigational for most elders. We propose a pragmatic pathway prioritizing diagnostic yield, minimizing low-value testing, and aligning interventions with patient goals and functional outcomes to reduce recurrences and support safer transitions.
Full article
(This article belongs to the Special Issue Cardiovascular Disease in the Elderly: Cardiogeriatric Assessment, Prevention, Treatment Outcomes and Perspectives)
►▼
Show Figures

Figure 1
Open AccessArticle
Role of NP-59 SPECT/CT in the Management of Mild Autonomous Cortisol Secretion
by
Łukasz Żukowski, Michał Szklarz, Dariusz Piechocki, Piotr Michał Szumowski, Małgorzata Mojsak, Saeid Abdelrazek, Izabela Sulima, Wojciech Matuszewski and Janusz Myśliwiec
J. Clin. Med. 2026, 15(16), 6302; https://doi.org/10.3390/jcm15166302 - 14 Aug 2026
Abstract
Background/Objectives: Recent advancements in medical imaging have provided tools that significantly enhance diagnostic precision and patient care. Among these, NP-59 SPECT/CT imaging has emerged as a promising method for assessing adrenal gland functionality. Current gaps in clinical practice, including the lack of
[...] Read more.
Background/Objectives: Recent advancements in medical imaging have provided tools that significantly enhance diagnostic precision and patient care. Among these, NP-59 SPECT/CT imaging has emerged as a promising method for assessing adrenal gland functionality. Current gaps in clinical practice, including the lack of specific diagnostic biomarkers and the paucity of clinical trials demonstrating the efficacy of adrenalectomy in alleviating comorbidities, necessitate the search for other diagnostic methods. Management becomes more challenging when bilateral adrenal adenomas are present. Demonstrating lateralization in cortisol secretion may greatly assist in treatment selection. Unilateral secretion of cortisol indicates autonomy and therefore adrenalectomy should be preferred. The aim of this study was to evaluate the usefulness of NP-59 SPECT/CT in the management of MACS. Methods: We investigated 20 patients with benign bilateral adrenal incidentalomas and MACS between the years 2023 and 2025. The first group (70%) consisted of patients with only hypertension, without additional comorbidities (hypertension only, HO). The second group (30%) consisted of hypertensive patients with additional comorbidities (hypertension with comorbidities, HC). Visualizations of adrenal glands metabolic activity were conducted using the SPECT/CT system after intravenous injection of NP-59. Abdominal SPECT/CT was performed at 3, 5, and 7 days after tracer injection. Lateralization was established when only single adrenal uptake occurred as early as the third day. Results: Six (30%) patients demonstrated lateralization during NP-59 SPECT scintigraphy. All these patients belonged to the HO group and accounted for 43% of it. Conclusions: NP-59 SPECT scintigraphy is valuable in the identification of unilateral cortisol secretion and guiding treatment decisions such as adrenalectomy versus conservative management. Prospective studies are needed to determine its clinical utility.
Full article
(This article belongs to the Special Issue Endocrine Tumors: Diagnosis, Treatment and Management—2nd Edition)
►▼
Show Figures

Figure 1
Open AccessArticle
Craniocervical Junction Morphology and Cerebrospinal Fluid Spaces at the Foramen Magnum in Idiopathic Intracranial Hypertension: Implications for Pathophysiology
by
Recai Engin, Melih Van, Fatih Tomakin, Cem Demirel, Hasan Şener, Muhammed Kırkgeçit, Ahmet Hakan Bayram, Mehlika Berra Pamuk, Bilge Piri Çınar and Ersoy Kocabicak
J. Clin. Med. 2026, 15(16), 6301; https://doi.org/10.3390/jcm15166301 - 14 Aug 2026
Abstract
Background: Although numerous magnetic resonance imaging (MRI) findings have been described in idiopathic intracranial hypertension (IIH), the potential contribution of craniocervical junction morphology to disease pathophysiology and diagnosis remains largely unexplored. This study aimed to evaluate foramen magnum morphology and cerebrospinal fluid (CSF)
[...] Read more.
Background: Although numerous magnetic resonance imaging (MRI) findings have been described in idiopathic intracranial hypertension (IIH), the potential contribution of craniocervical junction morphology to disease pathophysiology and diagnosis remains largely unexplored. This study aimed to evaluate foramen magnum morphology and cerebrospinal fluid (CSF) spaces at the craniocervical junction in patients with IIH and to investigate their associations with disease severity and diagnostic performance. Methods: In this retrospective case–control study, 70 patients diagnosed with IIH according to the modified Dandy criteria and 70 age- and sex-matched controls were included. Brain MRI examinations were retrospectively reviewed. Optic nerve sheath diameter, optic nerve tortuosity angle, foramen magnum anteroposterior and transverse diameters, foramen magnum area, foramen magnum index, and anterior and posterior subarachnoid CSF spaces were measured. Correlation analyses with lumbar puncture opening pressure and papilledema grade were performed. Independent imaging predictors of IIH were identified using multivariable logistic regression analysis, and diagnostic performance was assessed using receiver operating characteristic (ROC) analysis. Results: Compared with controls, patients with IIH demonstrated significant alterations in craniocervical junction morphology, including smaller foramen magnum anteroposterior diameter, foramen magnum area, foramen magnum index, and anterior subarachnoid CSF space, together with increased optic nerve sheath diameter and reduced optic nerve tortuosity angle (all p < 0.001). Foramen magnum morphometric parameters and anterior subarachnoid CSF space were significantly associated with both lumbar puncture opening pressure and papilledema grade. Multivariable logistic regression identified optic nerve sheath diameter (OR = 2.143, p = 0.002), optic nerve tortuosity angle (OR = 0.925, p < 0.001), and foramen magnum index (OR = 0.526 per 0.1-unit increase, p = 0.001) as independent imaging predictors of IIH. The combined prediction model demonstrated excellent diagnostic performance (AUC = 0.901), with 81.4% sensitivity and 87.1% specificity. Conclusions: Craniocervical junction morphometric features and subarachnoid CSF spaces at the foramen magnum differed between patients with IIH and controls and may provide complementary imaging information. These cross-sectional associations do not establish whether the observed differences are pre-existing anatomical characteristics or secondary changes related to chronically elevated intracranial pressure. Prospective multicenter studies incorporating dynamic CSF-flow imaging are warranted to validate these findings and clarify the temporal relationship between these morphometric features and disease development.
Full article
(This article belongs to the Section Clinical Neurology)
►▼
Show Figures

Figure 1
Open AccessArticle
Integrated Prognostic Stratification After Perioperative FLOT in Gastric and Gastroesophageal Junction Adenocarcinoma: A Multicenter Real-World Study
by
Seda Jeral Evinç, Zeliha Birsin, Selin Cebeci, Ahmet Başgöze, Çağla Eyüpler Akmercan, Tuğba Kaya, Burak Paçacı, Murat Sarı, İlknur Deliktaş Onur, Ayberk Bayramgil, Özgecan Dülger Kaya, Lamia Şeker Can, Hamza Abbasov, Emir Çerme, Ebru Çiçek, Süheyla Atak, Süleyman Sami Güzel, Kubilay Tay, Nebi Serkan Demirci and Özkan Alan
J. Clin. Med. 2026, 15(16), 6300; https://doi.org/10.3390/jcm15166300 - 14 Aug 2026
Abstract
Background/Objectives: Outcomes after perioperative FLOT for gastric and gastroesophageal junction adenocarcinoma remain variable, even among patients treated with curative intent. Although postoperative pathological findings are central to risk assessment, they do not fully capture patient-related factors that may influence recovery, treatment completion,
[...] Read more.
Background/Objectives: Outcomes after perioperative FLOT for gastric and gastroesophageal junction adenocarcinoma remain variable, even among patients treated with curative intent. Although postoperative pathological findings are central to risk assessment, they do not fully capture patient-related factors that may influence recovery, treatment completion, and survival. This multicenter study evaluated routinely available clinical, laboratory, and pathological variables and assessed whether integrating these variables could improve postoperative prognostic stratification. Methods: We retrospectively analyzed 173 patients with locally advanced gastric or gastroesophageal junction adenocarcinoma treated with perioperative FLOT across seven oncology centers in Türkiye. Overall survival (OS) was the primary endpoint. Baseline inflammatory/nutritional status, pretreatment carcinoembryonic antigen (CEA), postoperative nodal status, and comorbidity burden were assessed. An exploratory modified FLOT Prognostic Score (mFPS) was constructed by assigning one point each for high inflammatory/nutritional risk, elevated CEA, ypN-positive disease, and age-adjusted Charlson Comorbidity Index ≥ 5. Results: At a median follow-up of 39.7 months, median OS was 41.4 months, with estimated 2-year and 5-year OS rates of 69% and 44%, respectively. Surgery was performed in 164 patients, and 83 patients completed planned adjuvant chemotherapy. In multivariable analysis, ypN-positive disease, higher comorbidity burden, and high inflammatory/nutritional risk were independently associated with shorter OS. Among the 126 patients with complete data available for all score components, the mFPS stratified patients into groups with significantly different outcomes: median overall survival was not reached in the low-risk group, compared with 56.1 months in the intermediate-risk group and 18.7 months in the high-risk group. Conclusions: Survival after perioperative FLOT was not determined by residual disease burden alone. Integrating postoperative nodal status with baseline host-related factors may help identify patients at increased risk of adverse outcomes following curative-intent treatment. The proposed score should be considered exploratory and requires external validation before clinical application.
Full article
(This article belongs to the Section Oncology)
►▼
Show Figures

Figure 1
Open AccessArticle
MCID, SCB, and PASS Thresholds After Percutaneous Trigger Finger Release With or Without Corticosteroid Injection
by
Recep Karasu, Mustafa Dinç and Gökay Eken
J. Clin. Med. 2026, 15(16), 6299; https://doi.org/10.3390/jcm15166299 - 14 Aug 2026
Abstract
Background/Objectives: Percutaneous A1 pulley release effectively treats trigger finger, but the additional benefit of concomitant corticosteroid injection remains debated. Moreover, minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) thresholds have not been well established for
[...] Read more.
Background/Objectives: Percutaneous A1 pulley release effectively treats trigger finger, but the additional benefit of concomitant corticosteroid injection remains debated. Moreover, minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) thresholds have not been well established for this procedure, limiting patient-centered interpretation of outcomes. Methods: This retrospective cohort study included 80 patients (40 per group) who underwent percutaneous trigger finger release alone (PR) or with adjunctive triamcinolone injection (PR+CS). Anchor-based MCID and SCB thresholds for QuickDASH (Quick Disabilities of the Arm, Shoulder and Hand), Michigan Hand Outcomes Questionnaire (MHQ), and visual analog scale (VAS) pain were derived using GROC as the external anchor, whereas PASS thresholds were derived using a dichotomous acceptable-state question; ROC analysis was used for all threshold estimates. Group comparisons incorporated effect sizes and responder analyses. Results: MCID thresholds were ΔVAS ≥ 3, ΔQuickDASH ≥ 19, and ΔMHQ ≥ 16.5; SCB thresholds were ΔVAS ≥ 4, ΔQuickDASH ≥ 25, and ΔMHQ ≥ 20; and PASS thresholds were 3-month VAS ≤ 4, QuickDASH ≤ 29, and MHQ ≥ 76. For MCID and SCB, MHQ showed the highest observed AUCs (0.899 and 0.946, respectively). Greater mean improvements in all change scores were observed in the PR+CS group than in the PR group (ΔQuickDASH 24.2 vs. 19.9, p < 0.001, d = 1.39; ΔMHQ 20.5 vs. 15.0, p < 0.001, d = 1.67). However, the magnitudes of the between-group differences did not reach the derived MCID or SCB thresholds. PASS achievement was numerically higher in the PR+CS group than in the PR group (75% vs. 55%), but this difference did not reach statistical significance (p = 0.061). Conclusions: Preliminary MCID, SCB, and PASS estimates were derived for percutaneous trigger finger release; the principal novelty lies in the procedure-specific SCB and PASS estimates, with the SCB estimates being, to our knowledge, the first reported for any trigger finger treatment modality. MHQ showed the highest observed AUCs for MCID and SCB, whereas QuickDASH showed the highest observed AUC for PASS, underscoring the complementary information provided by the three instruments. Although greater mean functional changes were observed in the PR+CS group, the magnitudes of the between-group differences did not reach the derived MCID or SCB thresholds. However, given the retrospective, non-randomized design, these between-group findings remain exploratory and hypothesis-generating and should be viewed as a patient-centered re-interpretation of an established clinical question rather than as new comparative evidence; no causal benefit of adjunctive corticosteroid injection can be inferred. Given the small anchor-defined derivation subgroups and the potential instability of the selected cut-offs, these candidate estimates require prospective external validation in independent cohorts before clinical application.
Full article
(This article belongs to the Section Orthopedics)
►▼
Show Figures

Figure 1
Open AccessArticle
Distal Tibial Oblique Osteotomy Combined with Strut Bone Allografting for the Treatment of Ankle Osteoarthritis with Varus Deformity: A Case Series
by
Meng-Chun Tsai, Yi-Hsuan Lee, Tung-Ying Lee, Yi-Chen Li, Kai-Chiang Yang and Chen-Chie Wang
J. Clin. Med. 2026, 15(16), 6298; https://doi.org/10.3390/jcm15166298 - 14 Aug 2026
Abstract
Background: Advanced varus ankle osteoarthritis is challenging because correction of malalignment must be balanced against preservation of the native ankle joint. This study evaluated the clinical and radiographic outcomes of distal tibial oblique osteotomy (DTOO) with structural strut allografting, which permits individualized correction
[...] Read more.
Background: Advanced varus ankle osteoarthritis is challenging because correction of malalignment must be balanced against preservation of the native ankle joint. This study evaluated the clinical and radiographic outcomes of distal tibial oblique osteotomy (DTOO) with structural strut allografting, which permits individualized correction and provides mechanical support to the osteotomy gap. Methods: This retrospective case series included 20 patients and 20 operated ankles with Takakura stage IIIa (n = 13) or IIIb (n = 7) varus ankle osteoarthritis who underwent DTOO with structural strut allografting between 2012 and 2024. Clinical outcomes included Manchester–Oxford Foot Questionnaire (MOXFQ), American Orthopaedic Foot & Ankle Society (AOFAS), 12-Item Short-Form Survey (SF-12), and Visual Analog Scale (VAS) pain scores. Radiographic parameters included tibial articular surface angle (TAS), tibial lateral surface angle (TLS), medial malleolar angle (MMA), talar tilt angle (TTA), and tibiotalar surface angle (TTS). Results: Significant improvements were observed at final follow-up. MOXFQ scores decreased from 57.66 ± 22.01 to 10.63 ± 9.72 (p < 0.001), AOFAS scores increased from 63.75 ± 15.17 to 85.45 ± 8.37 (p < 0.001), and VAS pain scores decreased from 4.30 ± 1.75 to 1.00 ± 1.30 (p < 0.001). The SF-12 PCS increased from 45.23 ± 8.48 to 47.96 ± 7.93 (p = 0.258), and the MCS increased from 53.51 ± 9.85 to 55.60 ± 4.75 (p = 0.377); neither change was statistically significant. Significant correction was achieved in TAS (p < 0.001), TLS (p < 0.001), MMA (p = 0.019), and TTS (p < 0.001), with no significant change in TTA (p = 0.336). All achieved radiographic union within 3 months postoperatively. Conclusions: DTOO with strut bone allografting enables alignment correction in advanced varus ankle osteoarthritis, including Takakura stage III, while preserving the ankle joint. This technique is an effective joint-preserving option for severe deformities.
Full article
(This article belongs to the Special Issue Foot and Ankle Surgery: Current Advances and Prospects)
►▼
Show Figures

Figure 1
Open AccessTechnical Note
From Medical Records to AI-Ready Datasets: A Practical Guide for Clinical Researchers
by
Catalin Anghel, Andreea Alexandra Anghel, Marian Viorel Craciun, Simona Moldovanu, Adina Cocu, Diana-Elena Vulpe, Calina Maier, Vasile Potop, Christiana Diana Maria Dragosloveanu, Constantin Adrian Andrei, Serban Dragosloveanu and Cristian Scheau
J. Clin. Med. 2026, 15(16), 6297; https://doi.org/10.3390/jcm15166297 - 14 Aug 2026
Abstract
Background: Medical artificial intelligence (AI), machine learning (ML), and deep learning (DL) studies frequently begin with datasets collected for routine care rather than for computational modeling. Such datasets may contain inconsistent variables, heterogeneous measurement time points, unexplained NaN values, poorly defined outcomes,
[...] Read more.
Background: Medical artificial intelligence (AI), machine learning (ML), and deep learning (DL) studies frequently begin with datasets collected for routine care rather than for computational modeling. Such datasets may contain inconsistent variables, heterogeneous measurement time points, unexplained NaN values, poorly defined outcomes, missing metadata, and insufficient documentation, which can compromise model development before any algorithm is selected. Methods: This Technical Note proposes a physician-facing Clinical AI-Readiness Guide for preparing medical datasets before AI-based analysis. The guide was developed as a practical framework organized around pre-modeling decisions, including the clinical task, cohort, minimum common dataset, outcome definition, predictor variables, measurement timing, missing-data logic, standardization, non-tabular data linkage, data dictionary, and validation readiness. Results: The proposed guide translates AI-readiness principles into concrete data-collection rules for clinical, laboratory, imaging, physiological-signal, textual, follow-up, and multimodal data. It emphasizes clinically consistent data acquisition, reliable target labeling, explicit missing-data logic, patient-level linkage, structured metadata, and validation feasibility. A structured checklist and scoring approach are also proposed as practical pre-modeling assessment tools to classify datasets as not ready, exploratory only, ML-ready with limitations, or AI-ready for model development. Conclusions: Medical AI-readiness should be established before model development begins. By helping physicians collect, structure, and document data more consistently, the proposed guide may improve collaboration between clinical and technical teams and reduce preventable dataset-related failures in medical AI research.
Full article
(This article belongs to the Section Clinical Guidelines)
►▼
Show Figures

Figure 1
Open AccessReview
Hematological Toxicities in the Modern Era of Melanoma Therapy
by
Rodica Anghel, Ana-Maria Zamfirescu-Deryder, Vlad-Luca Moga, Antonia-Ruxandra Folea, Radu-Valeriu Toma, Andreea-Iren Șerban and Liviu Bîlteanu
J. Clin. Med. 2026, 15(16), 6296; https://doi.org/10.3390/jcm15166296 - 14 Aug 2026
Abstract
Background/Objectives: The advent of immune checkpoint inhibitors (ICIs) and targeted therapies has revolutionized advanced melanoma treatment but introduced unique immune-related adverse events (irAEs). Hematological irAEs (Hem-irAEs) are rare but carry disproportionately high morbidity and mortality. This review systematically synthesizes current literature to comprehensively
[...] Read more.
Background/Objectives: The advent of immune checkpoint inhibitors (ICIs) and targeted therapies has revolutionized advanced melanoma treatment but introduced unique immune-related adverse events (irAEs). Hematological irAEs (Hem-irAEs) are rare but carry disproportionately high morbidity and mortality. This review systematically synthesizes current literature to comprehensively understand the incidence, pathophysiology, clinical presentation, and management of Hem-irAEs in modern melanoma therapy. Methods: A comprehensive Web of Science literature search (January 2015 to January 2026) identified studies reporting hematological adverse events associated with melanoma immunotherapy and targeted therapies. After screening 2274 records, 130 relevant studies were included for quantitative data extraction, focusing on incidence rates and toxicity grading. Results: Hem-irAEs occur infrequently (under 4% overall incidence for ICIs) but possess staggering mortality rates between 12% and 15.5%. The most common manifestations are immune thrombocytopenia (ITP), autoimmune hemolytic anemia, and neutropenia. Combination regimens significantly amplify toxicity frequency and severity. Diagnosis requires meticulous baseline monitoring and bone marrow biopsies to differentiate peripheral destruction from central marrow failure. First-line management mandates ICI discontinuation and high-dose corticosteroids, utilizing targeted second-line immunosuppressants for refractory syndromes. Conclusions: Hem-irAEs embody a profound clinical paradox: while mild toxicities often herald a robust anti-tumor response, severe hematological events drastically increase non-cancer mortality, negating these oncological benefits. Navigating this “double-edged sword” demands a paradigm shift toward proactive risk stratification. Integrating predictive biomarkers including baseline autoantibodies, Human Leukocyte Antigens (HLA) profiling, and systemic inflammatory indices is crucial to identify vulnerable populations before treatment. Optimizing outcomes requires highly personalized vigilance to balance the life-saving efficacy of immunotherapy against the catastrophic threat of hematopoietic failure.
Full article
(This article belongs to the Special Issue New Perspectives in the Diagnosis and Management of Skin Cancer)
►▼
Show Figures

Figure 1
Open AccessArticle
Awareness of Menopause and Health Risks Among Reproductive-Age Women in Latvia
by
Jānis Jurkāns, Jeļizaveta Kolosovska and Elizabete Ārgale
J. Clin. Med. 2026, 15(16), 6295; https://doi.org/10.3390/jcm15166295 - 14 Aug 2026
Abstract
Background/Objectives: The menopausal transition is a period of increasing cardiometabolic risk and a window for prevention, yet preparation is often delayed until symptoms appear. Latvia has a high cardiovascular mortality burden, but population-specific menopause-awareness data are limited. This study aimed to describe
[...] Read more.
Background/Objectives: The menopausal transition is a period of increasing cardiometabolic risk and a window for prevention, yet preparation is often delayed until symptoms appear. Latvia has a high cardiovascular mortality burden, but population-specific menopause-awareness data are limited. This study aimed to describe item-level awareness among women aged 18–49 years in Latvia, compare age groups, and explore associated factors. Methods: An exploratory, anonymous, cross-sectional online convenience survey included 431 women aged 18–49 years in Latvia recruited through paid social media posts. An investigator-designed 47-item Latvian questionnaire was used. Primary outcomes were item-level responses to menopause-awareness Likert statements, summarized using medians, interquartile ranges, and dichotomized evidence-aligned proportions. A study-specific 10-item composite awareness score was constructed post hoc as a secondary hypothesis-generating measure. Analyses used chi-square tests, nonparametric tests, and exploratory multivariable linear regression. Results: Recognition of hot flushes (93.0%), that symptoms may appear before age 50 (91.6%), and vaginal dryness (79.8%) was high, whereas awareness that menopause may increase cardiovascular risk was limited (50.3%). Nine out of ten items showed no significant age-group difference; one reverse-keyed memory item showed a small nominal association. Composite awareness scores did not differ by age group, education level, or gynaecologist visit frequency. Internal consistency was modest (Cronbach’s α = 0.688), and the regression model explained limited variance (R2 = 0.083; adjusted R2 = 0.052). Previous information-seeking (B = 1.85, 95% CI 0.79–2.95, p < 0.001) and underweight BMI (B = −5.91, 95% CI −8.96 to −2.85, p < 0.001; n = 12) were independently associated with the composite awareness score. Overall, 72.6% considered educating younger women important. Conclusions: In this exploratory convenience sample, strong symptom recognition coexisted with limited cardiovascular-risk awareness, supporting earlier menopause education in Latvia that integrates cardiometabolic prevention.
Full article
(This article belongs to the Special Issue Gynecologic and Obstetric Pathologies: From Birth to Menopause (Third Edition))
Open AccessArticle
Association Between Immediate Postoperative Pulse Pressure and Three-Year All-Cause Mortality After Hip Fracture Surgery in Older Adults: A Post Hoc Analysis of a Prospective Cohort
by
Feng Gao, Ruijiang Li, Yimin Chen, Shanbin Xu, Yixiao Chen, Gang Liu, Jing Zhang, Minghui Yang and Xinbao Wu
J. Clin. Med. 2026, 15(16), 6294; https://doi.org/10.3390/jcm15166294 - 14 Aug 2026
Abstract
Objectives: The prognostic relevance of postoperative blood pressure after return to the ward is unclear. In this exploratory post hoc analysis, we investigated the associations of postoperative systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and pulse pressure (PP)
[...] Read more.
Objectives: The prognostic relevance of postoperative blood pressure after return to the ward is unclear. In this exploratory post hoc analysis, we investigated the associations of postoperative systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and pulse pressure (PP) with three-year all-cause mortality in older hip fracture patients. Methods: This single-centre post hoc analysis used prospectively collected data from patients aged 65 years or older who underwent hip fracture surgery under neuraxial anaesthesia between November 2018 and November 2019. Immediate postoperative blood pressure was defined as the first non-invasive cuff measurement recorded after return to the ward. PP was calculated as SBP minus DBP, and MAP as (SBP + 2 × DBP)/3. All 1052 patients were included in time-to-event analyses; patients lost to follow-up were right-censored on the date they were last known to be alive. Each blood pressure parameter was assessed in a separate adjusted Cox proportional hazards model. Restricted cubic splines were used to assess nonlinearity. Results: Among 865 patients with known three-year vital status, 192 had died and 673 were alive; 187 patients were censored before three years. Mean PP was lower among patients who died than among survivors (58.68 mmHg (SD 19.45) vs. 62.46 mmHg (SD 20.81); p = 0.019). Each 10 mmHg increase in PP was associated with a lower hazard of mortality (adjusted hazard ratio (HR) 0.914, 95% confidence interval (CI) 0.834 to 0.990; p = 0.033). Spline analysis showed an overall association for PP (p = 0.033), with no evidence of nonlinearity (p = 0.201). Continuous SBP, DBP, and MAP, and DBP < 60 mmHg were not independently associated with mortality. Conclusions: In this exploratory post hoc analysis, lower immediate postoperative PP was associated with a higher risk of three-year all-cause mortality. But PP should not be interpreted as a causal or therapeutic target.
Full article
(This article belongs to the Section Orthopedics)
►▼
Show Figures

Figure 1
Open AccessTechnical Note
Physician-Modified Cook Zenith Alpha Thoracic Endovascular Graft with Preservation of Active Fixation Barbs: A Step-by-Step Technical Guide
by
Emiel W. M. Huistra, Wajdi Alrawi, Ignace F. J. Tielliu, Samuel Saers, Clark J. Zeebregts and Robert C. Lind
J. Clin. Med. 2026, 15(16), 6293; https://doi.org/10.3390/jcm15166293 - 14 Aug 2026
Abstract
Physician-modified endografts (PMEGs) represent an important treatment option for urgent and semi-urgent complex abdominal aortic aneurysms (cAAAs). The Zenith Alpha Thoracic Endovascular Graft (Cook Medical, Bloomington, IN, USA) is a common choice for PMEGs due to its low strut interference, albeit at the
[...] Read more.
Physician-modified endografts (PMEGs) represent an important treatment option for urgent and semi-urgent complex abdominal aortic aneurysms (cAAAs). The Zenith Alpha Thoracic Endovascular Graft (Cook Medical, Bloomington, IN, USA) is a common choice for PMEGs due to its low strut interference, albeit at the cost of requiring removal of the proximal fixation barbs for resheathing—a process that remains technically challenging. The current article details a step-by-step approach on how to modify an Alpha thoracic endograft without requiring removal of the proximal barbs. The Zenith Alpha Thoracic Endovascular Graft is fully unsheathed on a sterile back-table and completely detached from the delivery system by removing the blue rotational handle. The grey positioner is removed from the introducer sheath. Next, a 0.018-inch guidewire is introduced distally through the inner positioner and retrieved via the exposed grey handle to function as a trigger wire. Following the creation and reinforcement of the fenestrations, circular diameter-reducing ties are constructed and secured using an insertion tool. The endograft is placed back on the delivery system and the guidewire is passed through the endograft fabric at the distal end and through the insertion tool, which is then removed. At the proximal end, the trigger wire is again passed through the endograft fabric, and both the proximal bare alignment stent and the distal end of the endograft are secured to the delivery system using 2-0 Prolene sutures (Ethicon Inc., Somerville, NJ, USA). The endograft is subsequently resheathed through the distal end of the introducer sheath using a tourniquet-assisted resheathing technique and a cut-off tip from an introducer sheath to guide the endograft’s passage through the valve. Using the current standardized modification protocol, a PMEG can be constructed using the Zenith Alpha Thoracic Endovascular Graft while preserving the active fixation barbs for the treatment of cAAAs.
Full article
(This article belongs to the Special Issue Aortic Aneurysms: Recent Advances in Diagnosis and Treatment: 2nd Edition)
►▼
Show Figures

Figure 1
Open AccessArticle
Association of Mean Arterial Pressure (MAP) with Mortality in Patients with Liver Cirrhosis Awaiting Transplantation
by
Yazan Omari, Ahmad Alomari, Ismail Althunibat, Abdulmalik Saleem, Thai Hau Koo, Yara Dababneh, Diana Jomaa, James Mo, Ahmad Abdulraheem and Syed-Mohammed Jafri
J. Clin. Med. 2026, 15(16), 6292; https://doi.org/10.3390/jcm15166292 - 14 Aug 2026
Abstract
Background/Objectives: In cirrhotic patients, guidelines generally recommend maintaining mean arterial pressure (MAP) ≥ 65 mmHg, but the prognostic impact of MAP in transplant candidates is unclear. This study aimed to evaluate the association between MAP and waitlist mortality and cirrhosis-related complications in patients
[...] Read more.
Background/Objectives: In cirrhotic patients, guidelines generally recommend maintaining mean arterial pressure (MAP) ≥ 65 mmHg, but the prognostic impact of MAP in transplant candidates is unclear. This study aimed to evaluate the association between MAP and waitlist mortality and cirrhosis-related complications in patients listed for liver transplantation. Methods: We conducted a retrospective cohort study of 103 adults (age ≥ 18 years) with cirrhosis listed for liver transplantation (MELD 20–24) at a single center (2019–2023). Patients with hepatocellular carcinoma were excluded. The primary outcome was death on the transplant waitlist (n = 9 events). Logistic regression was used to assess the association of MAP (per 1 mmHg) with mortality. Continuous variables were compared using the t-test, and categorical variables were compared using the chi-square test; p < 0.05 was considered significant. Results: Mean MAP at listing was significantly higher in survivors than non-survivors (83.2 ± 9.4 vs. 76.9 ± 8.7 mmHg; p = 0.04). In logistic regression, higher MAP was associated with lower odds of waitlist death (unadjusted odds ratio [OR] per 1 mmHg increase = 0.94; 95% confidence interval [CI] 0.89–0.99; p = 0.041). Subgroup analysis showed a significant inverse association between MAP and hepatorenal syndrome (HRS) (OR per 1 mmHg = 0.94; 95% CI 0.89–0.98; p = 0.011), whereas MAP was not significantly associated with hepatic encephalopathy, ascites, or variceal bleeding (all p > 0.2). Conclusions: Among the cirrhotic patients listed for transplantation, lower MAP at baseline is associated with waitlist mortality and hepatorenal syndrome. These findings should be interpreted cautiously given the small number of events and require validation in larger cohorts.
Full article
(This article belongs to the Special Issue Contemporary Management of Acute and Chronic Liver Disease: Advances in Diagnosis and Therapy)
►▼
Show Figures

Figure 1
Open AccessReview
Ocular Blood Flow in Eyes with Myopia and Glaucoma: From Pathophysiology to Clinical Implications
by
Naoki Takahashi, Naoki Kiyota, Akiko Hanyuda, Satoru Tsuda and Toru Nakazawa
J. Clin. Med. 2026, 15(16), 6291; https://doi.org/10.3390/jcm15166291 - 14 Aug 2026
Abstract
The global prevalence of myopia is increasing, and the combination of myopia and glaucoma is widely expected to become an important clinical and public health issue. Myopic eyes undergo axial elongation and posterior pole remodeling, leading to optic disc tilt, peripapillary deformation, choroidal
[...] Read more.
The global prevalence of myopia is increasing, and the combination of myopia and glaucoma is widely expected to become an important clinical and public health issue. Myopic eyes undergo axial elongation and posterior pole remodeling, leading to optic disc tilt, peripapillary deformation, choroidal thinning, and altered spatial relationships between the optic nerve head and its vascular supply. Glaucomatous optic neuropathy is associated with retinal ganglion cell damage, lamina cribrosa deformation, and ocular blood flow impairment. Recent advances in optical coherence tomography angiography and laser speckle flowgraphy have enabled noninvasive assessment of retinal, peripapillary, choroidal, and optic nerve head circulation. These modalities have revealed reduced radial peripapillary capillary density, choroidal microvasculature dropout, and reduced optic nerve head tissue blood-flow signal in glaucomatous eyes. In eyes with myopia and glaucoma, myopia-related structural deformation and glaucoma-associated perfusion abnormalities may coexist and show sectoral correspondence with neural damage, particularly in regions related to the central visual field. This review summarizes the anatomical background of ocular blood flow, myopia-induced structural and vascular changes, glaucoma-associated blood flow impairment, and their interaction in eyes with myopia and glaucoma. Potential therapeutic approaches targeting ocular blood flow are also discussed, although evidence beyond intraocular pressure reduction remains limited.
Full article
(This article belongs to the Special Issue Myopic Optic Neuropathy (MON) and Glaucomatous Optic Neuropathy (GON): Current Concepts and Clinical Implications)
►▼
Show Figures

Figure 1
Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Early Career Editorial Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
14 July 2025
Meet Us Virtually at the 1st International Online Conference on Hematology, 28–30 October 2026
Meet Us Virtually at the 1st International Online Conference on Hematology, 28–30 October 2026
14 August 2026
Journal of Clinical Medicine | Highly Cited Papers Published in 2024–2025 in Web of Science (II)
Journal of Clinical Medicine | Highly Cited Papers Published in 2024–2025 in Web of Science (II)
Topics
Topic in
Cancers, Diagnostics, Gastrointestinal Disorders, JCM, Current Oncology
Metastatic Colorectal Cancer: From Laboratory to Clinical Studies, 2nd Edition
Topic Editors: Ioannis Ntanasis-Stathopoulos, Diamantis I. TsilimigrasDeadline: 20 August 2026
Topic in
Cells, Immuno, IJMS, JCM, Allergies, Dermato
Skin Barrier Function and Immune Mediators as Key Therapeutic Targets of Main Inflammatory Diseases
Topic Editors: Marco Manfredini, Carlo PincelliDeadline: 31 August 2026
Topic in
Biomedicines, Clinics and Practice, Diagnostics, JCM, Rheumato
Rheumatic Disorder: From Basic Science to Clinical Practice—2nd Edition
Topic Editors: Andreina Manfredi, Caterina Vacchi, Giulia CassoneDeadline: 20 September 2026
Topic in
JCM, Pharmaceuticals, Pharmaceutics, Pharmacy, Healthcare
Optimization of Drug Utilization and Medication Adherence
Topic Editors: Enrica Menditto, Sara Mucherino, Ignacio Aznar-LouDeadline: 30 October 2026
Conferences
Special Issues
Special Issue in
JCM
Redefining Hemodialysis: Beyond Diffusion to Precision Therapy
Guest Editors: Stefano Stuard, Sagar NigwekarDeadline: 15 August 2026
Special Issue in
JCM
Hypertension and Cardiovascular Disease: Clinical Updates and Perspectives: 2nd Edition
Guest Editors: Valeria Visco, Nicola VirtuosoDeadline: 15 August 2026
Special Issue in
JCM
Advances in the Diagnosis, Treatment and Prognosis of Aortic Stenosis: 2nd Edition
Guest Editor: Rita MilewskiDeadline: 15 August 2026
Special Issue in
JCM
Neurovascular Canvas: From Basic Science to Clinical Breakthroughs
Guest Editors: Ciro De Luca, Nicola Giannini, Alessandro ViganòDeadline: 15 August 2026
Topical Collections
Topical Collection in
JCM
Pediatric and Adolescent Gynecology
Collection Editor: Panagiotis Christopoulos


